Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Head and Neck Cancer

  Free Subscription

Articles published in Int J Pediatr Otorhinolaryngol

Retrieve available abstracts of 23 articles:
HTML format

Single Articles

    July 2022
  1. SAHYOUNI G, Osterbauer B, Park S, Paik C, et al
    Incidence of thymic tissue in pediatric thyroidectomy.
    Int J Pediatr Otorhinolaryngol. 2022;158:111168.
    PubMed     Abstract available

    June 2022
  2. NEWFIELD RS, Jiang W, Sugganth DX, Hantash FM, et al
    Mutational analysis using next generation sequencing in pediatric thyroid cancer reveals BRAF and fusion oncogenes are common.
    Int J Pediatr Otorhinolaryngol. 2022;157:111121.
    PubMed     Abstract available

    February 2022
  3. YOU P, Dimachkieh A, Yu J, Buchanan E, et al
    Decannulation protocol for short term tracheostomy in pediatric head and neck tumor patients.
    Int J Pediatr Otorhinolaryngol. 2022;153:111012.
    PubMed     Abstract available

    January 2022
  4. TAWDE A, Jeyakumar A
    Surveillance, Epidemiology, and End Results Database update for pediatric thyroid carcinomas incidence and survival trends 2000-2016.
    Int J Pediatr Otorhinolaryngol. 2022;153:111038.
    PubMed     Abstract available

    October 2021
  5. POOL C, Gates CJ, Patel VA, Carr MM, et al
    Juvenile nasopharyngeal angiofibroma: National practice patterns and resource utilization via HCUP KID.
    Int J Pediatr Otorhinolaryngol. 2021;149:110871.
    PubMed     Abstract available

  6. KOTOWSKI M, Szydlowski J
    Radiological diagnostics in nasal dermoids: Pitfalls, predictive values and literature analysis.
    Int J Pediatr Otorhinolaryngol. 2021;149:110842.
    PubMed     Abstract available

    August 2021
  7. PERSON L, Lacour B, Faure L, Guissou S, et al
    Childhood head and neck cancer in France: Incidence, survival and trends from 2000 to 2015.
    Int J Pediatr Otorhinolaryngol. 2021;150:110858.
    PubMed     Abstract available

    May 2021
  8. BERGER MH, Lehrich BM, Yasaka TM, Fong BM, et al
    Characteristics and overall survival in pediatric versus adult esthesioneuroblastoma: A population-based study.
    Int J Pediatr Otorhinolaryngol. 2021;144:110696.
    PubMed     Abstract available

  9. RAMSEY T, Curran K, Mouzakes J, Gildener-Leapman N, et al
    A SEER database study of malignant teratomas in the head and neck region.
    Int J Pediatr Otorhinolaryngol. 2021;144:110672.
    PubMed     Abstract available

    April 2021
  10. BRUSS DM, Kovacs AJ, Kashmiri H, Huoh KC, et al
    Initial outcomes at a nascent tertiary pediatric thyroid surgical center.
    Int J Pediatr Otorhinolaryngol. 2021;143:110639.
    PubMed     Abstract available

  11. JENSEN JS, Gronhoj C, Garset-Zamani M, Westergaard-Nielsen M, et al
    Incidence and survival of salivary gland cancer in children and young adults in Denmark: A nation-wide study for the period 1990-2015.
    Int J Pediatr Otorhinolaryngol. 2021;143:110637.
    PubMed     Abstract available

    March 2021
  12. CURRY SD, Jiang ZY, Jain KS
    Population-based survival of pediatric rhabdomyosarcoma of the head and neck over four decades.
    Int J Pediatr Otorhinolaryngol. 2021;142:110599.
    PubMed     Abstract available

    January 2021
  13. KNANEH-MONEM H, Osterbauer B, Hochstim C
    Tracheal squamous metaplasia in children with endotracheal intubation or tracheostomy.
    Int J Pediatr Otorhinolaryngol. 2021;140:110549.
    PubMed     Abstract available

  14. FORSYTH AM, Camilon PR, Tracy L, Levi JR, et al
    Pediatric laryngeal tumors and demographics, management, and survival in laryngeal squamous cell carcinoma.
    Int J Pediatr Otorhinolaryngol. 2021;140:110507.
    PubMed     Abstract available

  15. ZHAO CX, Dombrowski ND, Perez-Atayde AR, Robson CD, et al
    Desmoid tumors of the head and neck in the pediatric population: Has anything changed?
    Int J Pediatr Otorhinolaryngol. 2021;140:110511.
    PubMed     Abstract available

  16. CARROLL WW, Farhood Z, White DR, Patel KG, et al
    Nasal dorsum reconstruction after pediatric nasal dermoid excision.
    Int J Pediatr Otorhinolaryngol. 2021;140:110502.
    PubMed     Abstract available

    July 2020
  17. ZHU H
    Silencing long non-coding RNA H19 combined with paclitaxel inhibits nasopharyngeal carcinoma progression.
    Int J Pediatr Otorhinolaryngol. 2020;138:110249.
    PubMed     Abstract available

  18. HASNAOUI M, Lahmar R, Ben Mabrouk A, Masmoudi M, et al
    Predictive epidemiological and clinical factors of nasopharyngeal carcinoma diagnosis: Adult versus pediatric population.
    Int J Pediatr Otorhinolaryngol. 2020;137:110203.
    PubMed     Abstract available

  19. RODRIGUES-FERNANDES CI, Perez-de-Oliveira ME, Aristizabal Arboleda LP, Fonseca FP, et al
    Clinicopathological analysis of oral Burkitt's lymphoma in pediatric patients: A systematic review.
    Int J Pediatr Otorhinolaryngol. 2020;134:110033.
    PubMed     Abstract available

    June 2020
  20. NGO DQ, Ngo QX, Van Le Q
    Pediatric thyroid cancer: Risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma.
    Int J Pediatr Otorhinolaryngol. 2020;133:110000.
    PubMed     Abstract available

    April 2020
  21. ARBOLEDA LPA, Hoffmann IL, Cardinalli IA, Gallagher KPD, et al
    Oral and maxillofacial cancer in pediatric patients: 30 years experience from a Brazilian reference center.
    Int J Pediatr Otorhinolaryngol. 2020;131:109879.
    PubMed     Abstract available

    March 2020
  22. MARODA AJ, Beckmann NA, Sheyn AM, Elijovich L, et al
    Trimodal embolization of juvenile nasopharyngeal angiofibroma with intracranial extension.
    Int J Pediatr Otorhinolaryngol. 2020;130:109805.
    PubMed     Abstract available

    February 2020
  23. RAWLINS KW, Zhan KY, Mattingly JK, Feldman AZ, et al
    Fibrous dysplasia mimicking a pediatric endolymphatic sac tumor.
    Int J Pediatr Otorhinolaryngol. 2020;129:109785.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.